IRIS Toxicological Review of Hexavalent Chromium (Interagency Science Consultation Draft, 2022)

Notice - This site contains archived material(s)

Archive disclaimer
Archive disclaimer
Archived files are provided for reference purposes only. These files are no longer maintained by the Agency and may be outdated. For current EPA information, go to www.epa.gov. It is EPA's policy to support reasonable accommodation to persons with disabilities, pursuant to the Rehabilitation Act of 1973, 29 U.S.C. 791. If you need assistance with accessing archived files, contact EPA's Reasonable Accommodations or submit a request using the Contact Us form.


Abstract

In October 2022, EPA publicly released the draft hexavalent chromium assessment for review and comment. The Toxicological Review and charge were reviewed internally by EPA and by other federal agencies and White House Offices before public release. Through the IRIS process, all written comments on IRIS assessments submitted by other federal agencies and White House Offices will be made publicly available. Accordingly, interagency comments and the interagency science consultation draft of the IRIS Toxicological Review of Hexavalent Chromium are posted on this site.

Cr(VI) is a naturally occurring metal that has been most commonly used commercially to prevent rust and corrosion and can be found in a variety of industries, including pigment manufacturing, chrome plating, and stainless-steel production. The general population may be exposed to Cr(VI) compounds when they inhale ambient air, and ingest water or food containing Cr(VI). EPA’s previous IRIS assessment on Cr(VI) was posted in 1998. This new draft assessment updates the information based on the latest science. The draft assessment provides a comprehensive systematic review of hundreds of studies on cancer and multiple noncancer health effects of inhalation and oral exposure to Cr(VI), resulting in a state-of-the-science human health assessment.

Impact/Purpose

The draft Toxicological Review of Hexavalent Chromium provides scientific support and rationale for the hazard and dose-response assessment pertaining to chronic exposure to hexavalent chromium via ingestion.

Citation

U.S. EPA. IRIS Toxicological Review of Hexavalent Chromium (Interagency Science Consultation Draft, 2022). U.S. Environmental Protection Agency, Washington, DC, EPA/635/R-21 /318, 2022.

History/Chronology

Date Description
01-Apr 2014EPA released preliminary meeting materials for chromium (VI), part 1, in preparation for the June 2014 Bimonthly Public Science Meeting.
02-Jun 2014EPA hosted a public science meeting to discuss preliminary meeting materials for chromium (VI), part 1.
03-Aug 2014EPA released preliminary meeting materials for chromium (VI), part 2, in preparation for the October 2014 Bimonthly Public Science Meeting.
04-Oct 2014EPA hosted a public science meeting to discuss preliminary meeting materials for chromium (VI), part 2.
05-Mar 2019EPA released the Systematic Review Protocol for the Hexavalent Chromium IRIS Assessment (Preliminary Assessment Materials). [Federal Register Notice Mar 15, 2019]
06-Apr 2019EPA announced that they will host a public science meeting on April 24, 2019 (by webinar) to discuss the draft document.
07-Feb 2022EPA initiated an interagency science consultation to review the draft toxicological review and charge to external peer reviewers.
08-Oct 2022EPA released the EPA-led Interagency Science Consultation draft (Feb 2022) report with interagency comments on the EPA website.